Directa Plus Share Discussion Threads

[bbluesky] 15/9/2021 08:40

National Highways trial of GiPave on the A1!! Starting 19 September



If successful can you imagine the upside.

[bad gateway] 08/9/2021 23:38

Stored to keep an eye on their press page.

[beergut] 16/8/2021 08:53

This is finally waking up

[hew] 09/8/2021 11:31

Still a way from profits but SETCAR seems to be building the Grafysorber® business:

Today's RNS (My abbreviation/edits): EU GRANT AWARD TO SETCAR:..... €1.15m with €0.6m non-refundable for two years .....will fund acquisition of additional equipment for decontamination of oil and other substance tanks and related services re soils contaminated with petroleum pollutants. Will leverage use of Grafysorber tech.......

[melody9999] 28/7/2021 22:22

agreed bad. Having sold a few weeks ago at 134p, I am back in again today - this looks a good entry point to me but DYOR.

[bad gateway] 28/7/2021 08:26

Starting to sound quite promising for graysorber.

"Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "This is our second major contract from OMV Petrom. Repeat business demonstrates a satisfied customer which has already seen our technology and services successfully applied to their operations.

"With the recent trend of the oil price, we expect more E&P companies will find our oil recovery services attractive. Grafysorber® is continuing to gain traction with and generate interest from the international oil and gas industry that require an environmentally friendly solution to treat produced water and sludges."


Loving the amount of promising verticals with this one.

[volsung] 14/7/2021 13:19

Looks like the former

[uncleoswald] 13/7/2021 06:23

Pennant forming on share price graph.
Will it break out above or below 120p??

[cordwainer] 12/7/2021 06:38

Reads like there's too much focus on seeking new applications and not enough on monetisation of the most viable existing ones.

[bad gateway] 12/7/2021 06:33

NONRNS but interesating and a heck of a lot of facemasks and cloth..

Directa Plus PLC
Publication of peer reviewed scientific paper
12 July 2021

Directa Plus plc

("Directa Plus" or the "Company")

Publication of Scientific Paper by Peer Reviewed Journal iScience

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, is pleased to announce that iScience has published a scientific paper titled "Graphene Nanoplatelet and Graphene Oxide Functionalization of Face Mask Materials Inhibits Infectivity of Trapped SARS-CoV-2". iScience is a peer-reviewed interdisciplinary open-access journal that publishes basic and applied research that advances a specific field across the life, physical, and earth sciences.

The paper provides scientific evidence that the Company's G+® graphene nanomaterials and those from graphene oxide present a critical opportunity to significantly increase face mask efficacy. In relation to the anti-SARS CoV2 capability of Directa Plus' G+® graphene, the paper certifies that G+® filter fabric treated with PU G+® can inactivate 97% of the virus while G+® cotton can inactivate 99% of the virus.

The Company's pristine G+® graphene is manufactured in a sustainable manner, without the use of chemicals, by exploiting water and mechanical treatment and is easily scalable. Combined with a process yield of 100%, G+® graphene is perfectly aligned to today's large supply chain needs. The production of graphene oxide is significantly more complex and expensive, involving the use of large amounts of chemicals. To date, the Company has treated and supplied more than 240,000 meters of G+® graphene fabrics and produced and delivered more than 1 million G+® filters to fight the COVID-19 pandemic.

The antibacterial and antiviral properties of the Directa's G+® pristine graphene nanoplatelets represent significant opportunities for Directa Plus in textile and biomedical applications. The efficacy of G+® and its non-toxic and sustainable production characteristics overcome the problems of the current state-of-the-art solutions that are based on metal-ion or halogen treatments, which could be dangerous to human health and detrimental to the environment.

Market demand for inherently antimicrobial (i.e. both antibacterial and antiviral) surfaces and components is significant and growing1. Directa Plus is working on a number of different applications to exploit the antimicrobial properties of G+®including apparel, upholstery and automotive applications, as well as composite and biomedical materials.

1 See for example and Antimicrobial Coatings Market Size and Share | Industry Forecast - 2026 (gminsights.com)

The paper is available at The authors include Massimiliano Papi and Valentina Palmieri (Catholic University Rome), Flavio De Maio and Gabriele Babini (Gemelli Polyclinic Rome) Laura Rizzi and Giulio Cesareo (Directa Plus) and, Patrick Soon-Shiong and Patricia Spilman (Nantworks).

Commenting on the paper, Giulio Cesareo, Founder and CEO of Directa Plus said: "Science underpins all of our work on applications, as this peer reviewed paper demonstrates. Our mission in this market is to offer customers the widest possible protection and we are already working on testing other types of bacteria and viruses to achieve that goal."

[bbluesky] 29/6/2021 05:58

Covid: Masks upgrade cuts infection risk, research finds
By David Shukman

[bad gateway] 23/6/2021 07:25

Agreed, decent update and glad to hear Setcar's picking up more business. Doesn't seem easy to get new tech applied by big industry players if they're gaining traction they're doing very well imho.

[beergut] 23/6/2021 07:07

Nice confident update this morning


23 June 2021

Directa Plus plc

("Directa Plus" or the "Company")

AGM Statement

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, provides an update on the current financial year to 31 December 2021 ahead of its Annual General Meeting to be held later today in Italy due to covid restrictions.

At the time of the announcement of the 2020 final results, the Company reported a strong performance in the first four months of 2021 with revenues increased by almost 50 per cent year-on-year to EUR2.8m. The Board is pleased to report that this strong revenue growth is continuing in the last two months of the current first half and that the Company is trading in line with market expectations. In the environmental vertical, growth momentum is continuing at the Group's subsidiary, Setcar, which is also benefitting from customer demand driven by the higher prices for oil reclaimed from its remediation services. In the emerging batteries vertical, the Board continues to be pleased with the progress being made with our partner NexTech in Li-S batteries.

Overall, the global market for graphene is estimated by different market research to be growing at a compound annual growth rate above 30 per cent, with a particular focus on high quality, sustainably produced graphene such as that produced by Directa Plus.

The Company continues to develop both its production technology and suitable applications for its products. This is reflected in the growing IP portfolio which now comprises 55 granted patents alongside an ever-deeper base of know-how covering the core production technology as well as the products launched or being developed by customers.

Directa Plus continues to explore new vertical markets and is in negotiations with additional potential partners.

For further information please visit hxxp://www.directa-plus.com/ or contact:

[beergut] 23/6/2021 07:07

Nice confident update this morning


23 June 2021

Directa Plus plc

("Directa Plus" or the "Company")

AGM Statement

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, provides an update on the current financial year to 31 December 2021 ahead of its Annual General Meeting to be held later today in Italy due to covid restrictions.

At the time of the announcement of the 2020 final results, the Company reported a strong performance in the first four months of 2021 with revenues increased by almost 50 per cent year-on-year to EUR2.8m. The Board is pleased to report that this strong revenue growth is continuing in the last two months of the current first half and that the Company is trading in line with market expectations. In the environmental vertical, growth momentum is continuing at the Group's subsidiary, Setcar, which is also benefitting from customer demand driven by the higher prices for oil reclaimed from its remediation services. In the emerging batteries vertical, the Board continues to be pleased with the progress being made with our partner NexTech in Li-S batteries.

Overall, the global market for graphene is estimated by different market research to be growing at a compound annual growth rate above 30 per cent, with a particular focus on high quality, sustainably produced graphene such as that produced by Directa Plus.

The Company continues to develop both its production technology and suitable applications for its products. This is reflected in the growing IP portfolio which now comprises 55 granted patents alongside an ever-deeper base of know-how covering the core production technology as well as the products launched or being developed by customers.

Directa Plus continues to explore new vertical markets and is in negotiations with additional potential partners.

For further information please visit hxxp://www.directa-plus.com/ or contact:

[volsung] 07/6/2021 10:01

To be fair TW did mention these as the best of the graphene stocks some time ago
Perhaps he was right

[velvetide] 07/6/2021 06:28

they shacked up quickly, maybe time to start talking hats

[bbluesky] 17/5/2021 09:43

Good brief summary of Cenkos 41 page note on the LSE. Very positive reading (actually mindblowing!) and they raise their target from 160p to 250p as a starter.

[bad gateway] 17/5/2021 06:57

Agreed the batteries vertical sound very promising for large revenue streams down the road.

"Lithium-Sulphur Batteries

Lithium Sulphur batteries are considered to be a superior battery technology to Lithium-Ion battery technology due to possessing a superior energy density, a significant cost advantage, a superior safety profile, and a less complex manufacturing process. With applications throughout the global supply chain, not least in electric vehicles, the scale of demand for these next generation batteries is likely to be enormous."

[velvetide] 17/5/2021 06:17

"We are particularly excited by our partnership with NexTech for high performance Lithium-Sulphur batteries where we believe we are making excellent progress"

[volsung] 05/5/2021 06:09

Das ist gut lieblings

[beergut] 05/5/2021 06:08

More good news

[beergut] 19/4/2021 06:05

More good news

[cordwainer] 09/4/2021 15:34

they've got balls, i'll give em that.

[bad gateway] 18/3/2021 08:12

Cenkos have done a note and don't expect cash to be a problem


"With other areas of the business equally exciting, such as the potential for virucidal filters and battery materials, we see Directa Plus as a highly attractive opportunity in the small cap and nano materials space. It proves exposure to key macro themes with a proven graphene production process, commercial products and strong customers. The strong trading also provides increased confidence that the path to profitability is funded as per our current expectations and we iterate our Buy recommendation ant 160p price target."

rest of the notes on lse forum already

[beergut] 18/3/2021 08:04

Looks like they will have share of an patents that come out of the work on the batteries, which could be very lucrative going forward